Globally, primary liver cancer is one of the most common and deadly cancers, and incidence is increasing. In Australia, the incidence of hepatocellular carcinoma (HCC) (the most common form of liver cancer) is also on the increase, with HCC now becoming the fastest increasing cause of death from cancer.
Furthermore, while HCC survival has improved over past decades, it remains among the lowest of all cancers. Also, Australian data on the variation in clinical pathways of HCC care are lacking. Though widely recognised and reported on for other cancers, Australian data assessing the impact of socio-demographic factors, clinical presentation, and management on HCC survival are still limited.
Using a population-based-linked cohort of HCC patients, we are examining factors associated with death after HCC diagnosis. Data from the Queensland Cancer registry, hospital admission and viral hepatitis notification are being used. In particular, we are examining the proportion of patients diagnosed with HCC who receive treatment, nature of treatment and impact on survival, by socio-demographic factors and location.